1-4 of 4
Monika Joks, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multicenter Prospective Study on Efficacy and Safety of Ponatinib in Patients with Chronic Myeloid Leukemia Resistant or Intolerant to Previous Therapy: A 3-Year Report

Tomasz Sacha, MDPhD, Elzbieta Szczepanek, Paulina Dumnicka, PhD, Joanna Gora-Tybor, MD PhD, Joanna Niesiobedzka-Krezel, MDPhD, Witold Prejzner, MD PhD, Ewa Wasilewska, MDPhD, Janusz Kloczko, MDPhD, Hanna Ciepluch, MD, Wioletta Makowska, MD, Elzbieta Patkowska, MD, Joanna Wasilewska, MD, Grazyna Bober, MD, Malgorzata Kopera, MDPhD, Ryszard Wichary, MD, Renata Kroll-Balcerzak, MDPhD, Tomasz Gromek, MDPhD, Malgorzata Wach, MDPhD, Anna Rudkowska-Kazanowska, MD, Magdalena Swiniarska, MD, Edyta Paczkowska, MDPhD, Ewa Medras, MD, Monika Joks, MD, Marta Oller, MD, Renata Kasza, MD, Aleksandra Kostyra, MD, Justyna Gil, MD, Olga Grzybowska-Izydorczyk, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-141523
Published: 2020
Journal Articles

Brentuximab Vedotin Alone and in Combination with Bendamustine As Salvage Therapy for Primary Refractory or Relapsed Hodgkin Lymphoma: Multicentre Experience of the Polish Lymphoma Research Group (PLRG)

Anna Czyz, MD PhD, Anna Lojko-Dankowska, Monika Joks, MD, Mieczyslaw Komarnicki, MD PhD, Monika Dlugosz-Danecka, MD PhD, Wojciech Jurczak, Justyna Rybka, MD PhD, Tomasz Wrobel, MD PhD, Ewa Paszkiewicz, Jan Walewski, MD, Dorota Hawrylecka, Joanna Drozd-Sokolowska, MD PhD, Edyta Subocz, Szymanska Agata, Magdalena Witkowska, Piotr Smolewski, MD PhD, Agnieszka Kolkowska, Ewa Lech Maranda, Wanda Knopinska-Posluszny, Sebastian Giebel, Jan Zaucha, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5375.
https://doi.org/10.1182/blood-2018-99-116610
Published: 2018
Journal Articles

Comparative Proteomic Profiling of Sera from Patients with Refractory Multiple Myeloma Reveals Pathways and Biomarkers Predicting Response to Bortezomib-Based Therapy

Dominik Dytfeld, MD PhD, Magdalena Luczak, PhD, Tomasz Szczepaniak, MD, Anna Przybylowicz-Chalecka, Msc, Blazej Ratajczak, MSc, Joanna Czerwinska-Rybak, MSc, Adam Nowicki, MD PhD, Monika Joks, MD PhD, Andrzej Jakubowiak, MD PhD, Mieczyslaw Komarnicki, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2092.
https://doi.org/10.1182/blood.V128.22.2092.2092
Published: 2016
Journal Articles

Comparative Proteomic Profiling of Refractory/Relapsed Multiple Myeloma Patient Plasma Cells Reveals Biomarkers and Pathways Involved in Bortezomib-Based-Therapy Resistance

Dominik Dytfeld, MD PhD, Magdalena Luczak, PhD, Anna Przybylowicz-Chalecka, Msc, Blazej Ratajczak, MSc, Adam Nowicki, MD, Joanna Czerwinska-Rybak, MSc, Monika Joks, MD PhD, Tomasz Szczepaniak, MD PhD, Bochenek Maciej, Andrzej Jakubowiak, MD PhD, Mieczyslaw Komarnicki, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2986.
https://doi.org/10.1182/blood.V126.23.2986.2986
Published: 2015